Status Quo Analysis on R&D Cooperation in Biomedical Field in China Based on Invention Co-patent
10.6039/j.issn.1001-0408.2017.31.04
- VernacularTitle:基于合作发明专利的我国生物医药领域研发合作现状分析
- Author:
Shengqiang JIANG
1
;
Peipei TIAN
;
Zimo SHA
;
Xiaoluan SUN
;
Xin LI
Author Information
1. 南京医科大学科技处
- Keywords:
R&D cooperation;
Invention co-patent;
Biomedicine;
Descriptive statistical
- From:
China Pharmacy
2017;28(31):4334-4337
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To put forward relevant suggestions for promoting the R&D cooperation in biomedical field in China. METHODS:Information of all invention co-patents in biomedical fields during 2000-2015 in patent database was collected,includ-ing year,patent name,application number,applicant,patent address,etc.,and descriptive statistical analysis was conducted. RE-SULTS:The number of invention co-patents in biomedical fields had been increasing year by year,and the number of invention co-patents in 2015 was about 9 times than that in 2000. Invention co-patents mainly came from Beijing,Shanghai and Guangdong,accounting for 49.1%. The top 15 applicants had 983 invention co-patents in total,accounting for 8.9% of the total number of co-patents,7 of which were enterprises. And in the invention co-patents applied by the top 10 cities for GDP ranking in 2014,inven-tion co-patents applied by enterprises,scientific research institutions(include hospitals)and universities accounted for 56.2% of all patents. CONCLUSIONS:The R&D cooperation in biomedical fields has mainly focused on a few developed provinces and cities, with low concentration of invention co-patents;the R&D cooperation is mainly led by enterprises,and hospitals have low participa-tion. The government should establish national biomedical information sharing platform,raise the R&D cooperation awareness of large-scale pharmaceutical enterprises and encourage hospitals to actively participate in R&D cooperation activities in biomedicine fields.
